Chemicals - Specialty
Compare Stocks
4 / 10Stock Comparison
KRO vs HUN vs TROX vs EMN
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals
Chemicals
Chemicals - Specialty
KRO vs HUN vs TROX vs EMN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals | Chemicals | Chemicals - Specialty |
| Market Cap | $811M | $2.56B | $1.34B | $8.43B |
| Revenue (TTM) | $1.88B | $5.69B | $2.92B | $8.64B |
| Net Income (TTM) | $-134M | $-324M | $-359M | $399M |
| Gross Margin | 10.1% | 12.9% | 5.8% | 19.8% |
| Operating Margin | -3.1% | -1.0% | -4.8% | 9.4% |
| Forward P/E | — | — | — | 12.5x |
| Total Debt | $577M | $2.73B | $3.59B | $5.08B |
| Cash & Equiv. | $37M | $429M | $211M | $566M |
KRO vs HUN vs TROX vs EMN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Kronos Worldwide, I… (KRO) | 100 | 72.2 | -27.8% |
| Huntsman Corporation (HUN) | 100 | 81.2 | -18.8% |
| Tronox Holdings plc (TROX) | 100 | 126.7 | +26.7% |
| Eastman Chemical Co… (EMN) | 100 | 108.2 | +8.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: KRO vs HUN vs TROX vs EMN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
KRO is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth -1.5%, EPS growth -228.0%, 3Y rev CAGR -1.2%
- 129.0% 10Y total return vs HUN's 57.6%
- Lower volatility, beta 1.57, Low D/E 76.9%, current ratio 2.70x
- -1.5% revenue growth vs EMN's -6.7%
HUN is the clearest fit if your priority is dividends.
- 5.7% yield, vs EMN's 4.5%
TROX is the clearest fit if your priority is momentum.
- +76.9% vs KRO's -1.2%
EMN carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 12 yrs, beta 1.36, yield 4.5%
- Beta 1.36, yield 4.5%, current ratio 1.37x
- Better valuation composite
- 4.6% margin vs TROX's -12.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -1.5% revenue growth vs EMN's -6.7% | |
| Value | Better valuation composite | |
| Quality / Margins | 4.6% margin vs TROX's -12.3% | |
| Stability / Safety | Beta 1.36 vs TROX's 2.37, lower leverage | |
| Dividends | 5.7% yield, vs EMN's 4.5% | |
| Momentum (1Y) | +76.9% vs KRO's -1.2% | |
| Efficiency (ROA) | 2.6% ROA vs KRO's -9.4%, ROIC 6.7% vs -1.9% |
KRO vs HUN vs TROX vs EMN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
KRO vs HUN vs TROX vs EMN — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
EMN leads in 3 of 6 categories
KRO leads 0 • HUN leads 0 • TROX leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
EMN leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EMN is the larger business by revenue, generating $8.6B annually — 4.6x KRO's $1.9B. EMN is the more profitable business, keeping 4.6% of every revenue dollar as net income compared to TROX's -12.3%. On growth, KRO holds the edge at +4.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $1.9B | $5.7B | $2.9B | $8.6B |
| EBITDAEarnings before interest/tax | -$9M | $160M | $166M | $1.2B |
| Net IncomeAfter-tax profit | -$134M | -$324M | -$359M | $399M |
| Free Cash FlowCash after capex | $35M | $135M | -$139M | $498M |
| Gross MarginGross profit ÷ Revenue | +10.1% | +12.9% | +5.8% | +19.8% |
| Operating MarginEBIT ÷ Revenue | -3.1% | -1.0% | -4.8% | +9.4% |
| Net MarginNet income ÷ Revenue | -7.1% | -5.7% | -12.3% | +4.6% |
| FCF MarginFCF ÷ Revenue | +1.9% | +2.4% | -4.8% | +5.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.1% | +0.7% | +3.0% | -4.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -126.1% | -3.3% | +7.1% | -40.8% |
Valuation Metrics
Evenly matched — HUN and EMN each lead in 2 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, EMN's 9.0x EV/EBITDA is more attractive than KRO's 40.7x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $811M | $2.6B | $1.3B | $8.4B |
| Enterprise ValueMkt cap + debt − cash | $1.4B | $4.9B | $4.7B | $12.9B |
| Trailing P/EPrice ÷ TTM EPS | -7.34x | -9.27x | -2.83x | 17.97x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | 12.50x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 5.59x |
| EV / EBITDAEnterprise value multiple | 40.71x | 19.64x | 16.80x | 8.96x |
| Price / SalesMarket cap ÷ Revenue | 0.44x | 0.45x | 0.46x | 0.96x |
| Price / BookPrice ÷ Book value/share | 1.08x | 0.86x | 0.92x | 1.41x |
| Price / FCFMarket cap ÷ FCF | — | 22.11x | — | 19.87x |
Profitability & Efficiency
EMN leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
EMN delivers a 6.7% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-30 for TROX. KRO carries lower financial leverage with a 0.77x debt-to-equity ratio, signaling a more conservative balance sheet compared to TROX's 2.48x. On the Piotroski fundamental quality scale (0–9), KRO scores 5/9 vs TROX's 2/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -17.0% | -8.1% | -30.4% | +6.7% |
| ROA (TTM)Return on assets | -9.4% | -4.6% | -7.7% | +2.6% |
| ROICReturn on invested capital | -1.9% | -0.6% | -0.3% | +6.7% |
| ROCEReturn on capital employed | -2.2% | -0.7% | -0.4% | +7.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 2 | 2 | 5 |
| Debt / EquityFinancial leverage | 0.77x | 0.92x | 2.48x | 0.84x |
| Net DebtTotal debt minus cash | $540M | $2.3B | $3.4B | $4.5B |
| Cash & Equiv.Liquid assets | $37M | $429M | $211M | $566M |
| Total DebtShort + long-term debt | $577M | $2.7B | $3.6B | $5.1B |
| Interest CoverageEBIT ÷ Interest expense | -2.32x | -1.08x | -1.16x | 2.22x |
Total Returns (Dividends Reinvested)
EMN leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in EMN five years ago would be worth $7,163 today (with dividends reinvested), compared to $4,493 for TROX. Over the past 12 months, TROX leads with a +76.9% total return vs KRO's -1.2%. The 3-year compound annual growth rate (CAGR) favors EMN at 1.1% vs HUN's -12.6% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +58.5% | +45.5% | +98.1% | +15.8% |
| 1-Year ReturnPast 12 months | -1.2% | +37.5% | +76.9% | +2.3% |
| 3-Year ReturnCumulative with dividends | -0.7% | -33.3% | -23.6% | +3.4% |
| 5-Year ReturnCumulative with dividends | -43.9% | -39.8% | -55.1% | -28.4% |
| 10-Year ReturnCumulative with dividends | +129.0% | +57.6% | +116.1% | +35.4% |
| CAGR (3Y)Annualised 3-year return | -0.2% | -12.6% | -8.6% | +1.1% |
Risk & Volatility
Evenly matched — HUN and EMN each lead in 1 of 2 comparable metrics.
Risk & Volatility
EMN is the less volatile stock with a 1.36 beta — it tends to amplify market swings less than TROX's 2.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HUN currently trades 92.7% from its 52-week high vs TROX's 79.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.57x | 1.73x | 2.37x | 1.36x |
| 52-Week HighHighest price in past year | $7.90 | $15.89 | $10.59 | $84.18 |
| 52-Week LowLowest price in past year | $4.08 | $7.30 | $2.86 | $56.11 |
| % of 52W HighCurrent price vs 52-week peak | +89.2% | +92.7% | +79.4% | +87.5% |
| RSI (14)Momentum oscillator 0–100 | 63.4 | 65.4 | 58.5 | 56.9 |
| Avg Volume (50D)Average daily shares traded | 350K | 6.2M | 3.1M | 1.5M |
Analyst Outlook
Evenly matched — HUN and EMN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: KRO as "Hold", HUN as "Hold", TROX as "Buy", EMN as "Buy". Consensus price targets imply 4.9% upside for EMN (target: $77) vs -29.1% for KRO (target: $5). For income investors, HUN offers the higher dividend yield at 5.74% vs KRO's 2.84%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $5.00 | $12.00 | $7.25 | $77.29 |
| # AnalystsCovering analysts | 7 | 33 | 17 | 35 |
| Dividend YieldAnnual dividend ÷ price | +2.8% | +5.7% | +3.6% | +4.5% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 0 | 12 |
| Dividend / ShareAnnual DPS | $0.20 | $0.85 | $0.30 | $3.30 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.1% | 0.0% | +1.2% |
EMN leads in 3 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 3 categories are tied.
KRO vs HUN vs TROX vs EMN: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is KRO or HUN or TROX or EMN a better buy right now?
For growth investors, Kronos Worldwide, Inc.
(KRO) is the stronger pick with -1. 5% revenue growth year-over-year, versus -6. 7% for Eastman Chemical Company (EMN). Eastman Chemical Company (EMN) offers the better valuation at 18. 0x trailing P/E (12. 5x forward), making it the more compelling value choice. Analysts rate Tronox Holdings plc (TROX) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — KRO or HUN or TROX or EMN?
Over the past 5 years, Eastman Chemical Company (EMN) delivered a total return of -28.
4%, compared to -55. 1% for Tronox Holdings plc (TROX). Over 10 years, the gap is even starker: KRO returned +129. 0% versus EMN's +35. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — KRO or HUN or TROX or EMN?
By beta (market sensitivity over 5 years), Eastman Chemical Company (EMN) is the lower-risk stock at 1.
36β versus Tronox Holdings plc's 2. 37β — meaning TROX is approximately 75% more volatile than EMN relative to the S&P 500. On balance sheet safety, Kronos Worldwide, Inc. (KRO) carries a lower debt/equity ratio of 77% versus 2% for Tronox Holdings plc — giving it more financial flexibility in a downturn.
04Which is growing faster — KRO or HUN or TROX or EMN?
By revenue growth (latest reported year), Kronos Worldwide, Inc.
(KRO) is pulling ahead at -1. 5% versus -6. 7% for Eastman Chemical Company (EMN). On earnings-per-share growth, the picture is similar: Huntsman Corporation grew EPS -44. 5% year-over-year, compared to -890. 0% for Tronox Holdings plc. Over a 3-year CAGR, KRO leads at -1. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — KRO or HUN or TROX or EMN?
Eastman Chemical Company (EMN) is the more profitable company, earning 5.
4% net margin versus -16. 2% for Tronox Holdings plc — meaning it keeps 5. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMN leads at 10. 6% versus -1. 7% for KRO. At the gross margin level — before operating expenses — EMN leads at 21. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is KRO or HUN or TROX or EMN more undervalued right now?
Analyst consensus price targets imply the most upside for EMN: 4.
9% to $77. 29.
07Which pays a better dividend — KRO or HUN or TROX or EMN?
All stocks in this comparison pay dividends.
Huntsman Corporation (HUN) offers the highest yield at 5. 7%, versus 2. 8% for Kronos Worldwide, Inc. (KRO).
08Is KRO or HUN or TROX or EMN better for a retirement portfolio?
For long-horizon retirement investors, Eastman Chemical Company (EMN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (4.
5% yield). Tronox Holdings plc (TROX) carries a higher beta of 2. 37 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (EMN: +35. 4%, TROX: +116. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between KRO and HUN and TROX and EMN?
Both stocks operate in the null sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: KRO is a small-cap quality compounder stock; HUN is a small-cap income-oriented stock; TROX is a small-cap income-oriented stock; EMN is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.